Clinical Trials in Vaasa, Finland

9 recruiting

Showing 115 of 15 trials

Recruiting
Phase 3

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled295 locationsNCT07028853
Recruiting
Phase 3

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled536 locationsNCT06492616
Recruiting
Phase 3

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled229 locationsNCT06077760
Recruiting
Phase 3

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma
Pfizer680 enrolled305 locationsNCT07144280
Recruiting
Phase 3

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Neoplasms, Lung
GlaxoSmithKline420 enrolled114 locationsNCT07099898
Recruiting
Phase 3

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer
Pfizer400 enrolled371 locationsNCT07062965
Recruiting
Phase 1Phase 2

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

Prostatic Neoplasms, Castration-Resistant
Merck Sharp & Dohme LLC220 enrolled77 locationsNCT06353386
Recruiting
Phase 3

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Bristol-Myers Squibb750 enrolled271 locationsNCT07361510
Recruiting
Phase 3

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Not Applicable

Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer

Smoking Cessation
Oulu University Hospital1,200 enrolled5 locationsNCT07331519
Recruiting
Not Applicable

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

CholedocholithiasisCholelithiasisCholecystectomy, Laparoscopic
Helsinki University Central Hospital400 enrolled12 locationsNCT07001423
Recruiting
Not Applicable

Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer

Rectal CancerRectal Adenocarcinoma
Tampere University Hospital200 enrolled13 locationsNCT06328361
Recruiting
Not Applicable

SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease

Cardiovascular DiseasesChronic Kidney DiseaseFrailty
Turku University Hospital400 enrolled3 locationsNCT06935786
Recruiting
Not Applicable

Finnish Venous Ulcer Study (FINNULCER Study)

Venous Leg Ulcer
Oulu University Hospital248 enrolled5 locationsNCT04737941
Recruiting
Not Applicable

The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care

SchizophreniaPsychotic DisordersSchizoaffective Disorder+2 more
University of Jyvaskyla85 enrolled1 locationNCT06005766